Searchable abstracts of presentations at key conferences in endocrinology
ISSN 1470-3947 (print)
| ISSN 1479-6848 (online)
Endocrine Abstracts
Menu
Search
Issues/Conferences
Cite
About
Our Services
Policies
Contact
Disclaimer
Search
Issues/Conferences
Cite
About
Our Services
Policies
Contact
Disclaimer
Previous issue
|
Volume 40
|
ESEBEC2016
|
Next issue
ESE Basic Endocrinology Course on Endocrine and Neuroendocrine Cancer 2016
All volumes
0105 UKINETS2024
0104 SFEIES24
0103 BSPED2024
0102 EYES2024
0101 ETA2024
0100 SFEEU2024
0099 ECE2024
0098 NANETS2023
0097 BES2023
0096 UKINETS2023
0095 BSPED2023
0094 SFEBES2023
0093 EYES2023
0092 ETA2023
0091 SFEEU2023
0090 ECE2023
0089 NANETS2022
0088 BES2022
0087 UKINETS2022
0086 SFEBES2022
0085 BSPED2022
0084 ETA2022
0083 EYES2022
0082 SFEEU2022
0081 ECE2022
0080 UKINETS2021
0079 BES2021
0078 BSPED2021
0077 SFEBES2021
0076 CHD2021
0075 EYES2021
0074 SFENCC2021
0073 ECE2021
0072 UKINETS2020
0071 BES2020
0070 ECE2020
0069 SFENCC2020
0068 UKINETS2019
0067 EYES2019
0066 BSPED2019
0065 SFEBES2019
0064 BES2019
0063 ECE2019
0062 EU2019
0061 OU2019
0060 UKINETS2018
0059 SFEBES2018
0058 BSPED2018
0057 BES2018
0056 ECE2018
0055 SFEEU2018
0054 NuclearReceptors2018
0053 OU2018
0052 UKINETS2017
0051 BSPED2017
0050 SFEBES2017
0049 ECE2017
0048 SFEEU2017
0047 Theranostics2016
0046 UKINETS2016
0045 BSPED2016
0044 SFEBES2016
0043 WCTD2016
0042 Androgens2016
0041 ECE2016
0040 ESEBEC2016
0039 BSPED2015
0038 SFEBES2015
0037 ECE2015
0036 BSPED2014
0035 ECE2014
0034 SFEBES2014
0033 BSPED2013
0032 ECE2013
0031 SFEBES2013
0030 BSPED2012
0029 ICEECE2012
0028 SFEBES2012
0027 BSPED2011
0026 ECE2011
0025 SFEBES2011
0024 BSPED2010
0023 BSPED2009
0022 ECE2010
0021 SFEBES2009
0020 ECE2009
0019 SFEBES2009
0018 MES2008
0017 BSPED2008
0016 ECE2008
0015 SFEBES2008
0014 ECE2007
0013 SFEBES2007
0012 SFE2006
0011 ECE2006
0010 SFE2005
0009 BES2005
0008 SFE2004
0007 BES2004
0006 SFE2003
0005 BES2003
0004 SFE2002
0003 BES2002
0002 SFE2001
Summary
Abstract Book
Programme
Volume Editors
Abstracts
Contents
ESE Basic Course on Endocrine and Neuroendocrine Cancer 2016
Advances in molecular pathogenesis of thyroid cancer
Advances in molecular pathogenesis of thyroid cancer
ea0040l1
L1 - Biography
ea0040lb1
Telomerase promoter mutations in cancer: beyond immortalization?
Telomerase promoter mutations in cancer: beyond immortalization?
ea0040l3
L3 - Biography
ea0040lb3
Molecular Targeted Therapy in Medullary and Well-Differentiated Thyroid Carcinoma
Molecular targeted therapy in medullary and well-differentiated thyroid carcinoma
ea0040l4
L4 - Biography
ea0040lb4
Endocrine cancer: in the light of recent molecular studies
Endocrine cancer: in the light of recent molecular studies
ea0040l5
L5 - Biography
ea0040lb5
The genomic landscape of pancreatic neuroendocrine tumors
The genomic landscape of pancreatic neuroendocrine tumors
ea0040l6
L6 - Biography
ea0040lb6
Anti-tumor effects of Semaphorin 4D blockade unravel a novel pro-invasive mechanism of vascular targeting agents in pNETs
Anti-tumor effects of Semaphorin 4D blockade unravel a novel pro-invasive mechanism of vascular targeting agents in pNETs
ea0040l8
L8 - Biography
ea0040lb8
Deciphering the antitumoral potential of stromal somatostatin receptor signal
Deciphering the antitumoral potential of stromal somatostatin receptor signal
ea0040l9
L9 - Biography
ea0040lb9
ALTered telomeres in pancreatic neuroendocrine tumors
ALTered telomeres in pancreatic neuroendocrine tumors
ea0040l10
L10 - Biography
ea0040lb10
New insights on adrenocortical tumors OMICs
New insights on adrenocortical tumors OMICs
ea0040l11
L11 - Biography
ea0040lb11
Identification of new familial pheochromocytoma/paraganglioma genes using next generation sequencing (NGS)
Identification of new familial pheochromocytoma/paraganglioma genes using next generation sequencing (NGS)
ea0040l12
L12 - Biography
ea0040lb12
Cellular and animal models in Pheochromocytoma/Paragangliomas research: Role of microenvironment
Cellular and animal models in pheochromocytoma/paragangliomas research: role of microenvironment
ea0040l13
L13 - Biography
ea0040lb13
Meet-the-Expert: From genetics to the bedside
Meet-the-expert: from genetics to the bedside
ea0040l15
L15 - Biography
ea0040lb15
AIP and the somatostatin signalling in pituitary tumours
AIP and the somatostatin signalling in pituitary tumours
ea0040l16
L16 - Biography
ea0040lb16
Truncated sst5 receptor variants in pituitary tumors and cancer
Truncated sst5 receptor variants in pituitary tumors and cancer
ea0040l17
L17 - Biography
ea0040lb17
Stem cells in pituitary … and in pituitary tumours?
Stem cells in pituitary... and in pituitary tumours?
ea0040l18
L18 - Biography
ea0040lb18
Gigantism, acromegaly and GPR101
Gigantism, acromegaly and GPR101
ea0040l19
L19 - Biography
ea0040lb19
The bright and dark side of transthyretin, a thyroxine plasma transporter
The bright and dark side of transthyretin, a thyroxine plasma transporter
ea0040l20
L20 - Biography
ea0040lb20
Oral Communications
(1)
A new chemotherapy combination (U0126+SN50) potentiates apoptosis in thyroid cancer but induced survival in normal thyroid
ea0040oc1
mTOR pathway activation in papillary thyroid carcinomas: associations and correlations
ea0040oc2
Mesoporous silica nanoparticles for somatostatin targeted Notch activation in animal model of pancreatic neuroendocrine cancer
ea0040oc3
TERT promoter mutations in pancreatic endocrine tumours are frequent in tumours from patients with hereditary syndromes
ea0040oc4
The anti-proliferative effect of metformin in a model of adrenocortical carcinoma
ea0040oc5
Norepinephrine transporter as a predictive marker of response to PI3K/mTOR inhibition in pheochromocytoma
ea0040oc6
Bifocal intracranial germinoma presenting as adipsic diabetes insipidus
ea0040oc7
Small cell lung carcinoma presenting as ophthalmoplegia due to pituitary metastases: case report
ea0040oc8
Poster Presentations
(1)
Genetic heterogeneity of medullary thyroid carcinoma
ea0040p1
Methimazole induced agranulocytosis side effect-not always a bad effect: case report
ea0040p2
Prevalence of BRAF V600E mutation in Romanian thyroid tumors patients
ea0040p3
Expression of osteopontin isoforms is related with thyroid cancer growth and invasion
ea0040p4
Mouse model of BRAFV600E-induced papillary thyroid carcinoma - summary of our results
ea0040p5
Toxicity of tyrosine kinase inhibitors in the treatment of thyroid cancer - a 10-year experience resume
ea0040p6
The genetic screening of RET proto-oncogene in Polish population during the past two decades
ea0040p7
Medullary thyroid cancer in a
RET
-negative patient with a germline
SDHB
mutation
ea0040p8
Case report of ACTH-secreting tumour of the liver
ea0040p9
A case of ectopic adrenocorticotropic hormone syndrome in bronchial carcinoid
ea0040p10
Acromegaly caused by hepatic metastasis of a pulmonary neuroendocrine tumor
ea0040p11
Ectopic cushing syndrome by an aggressive gastroenteropancreatic neuroendocrine carcinoma
ea0040p12
Multiple endocrine neoplasia type 1 - retrospective analysis of five families
ea0040p13
A novel germline mutation of the MEN 1 gene associated with multiple endocrine neoplasia type 1 (MEN1 syndrome) followed over three generations of a family
ea0040p14
Post-pancreatectomy persistent adult nesidioblastosis: follow-up of 24 years
ea0040p15
Insulinomas at Sao Joao Hospital between 1980 and 2015
ea0040p16
Aggressive multifocal angiomyxoma - a surgical challenge
ea0040p17
Massive bilateral pheocromocitomas: a rare case
ea0040p18
Recurrent adrenal pheochromocytoma - a benign condition?
ea0040p19
The importance of fully investigating adrenal incidentaloma: two pheochromocytoma cases
ea0040p20
Pituicytoma: a rare tumor
ea0040p21
Hypothyroidism and thyroid autoimmunity in metastatic renal cell carcinoma patients treated with sunitinib: 2 years follow-up of long survivors from a sigle centre experience
ea0040p22
A rare synchronous presentation of aldosterone producing adenoma and multifocal papillary thyroid microcarcinoma
ea0040p23
Functional role of somatostatin receptor subtype 1 (sst1) in prostate cancer: an in vitro approach
ea0040p24
Metformin suppressed the proliferation of prostate cancer cells in vitro and reduced prostate tumor growth in vivo under low-fat and, especially, under high-fat fed conditions
ea0040p25